The endocannabinoid system is involved in various physiological processes, including inflammation, immunomodulation, and suppression of different cancers, including breast cancer; thus, CYP4X1 may play a role in the response to anticancer chemotherapy via physiological processes. Here, CYP4X1 is linked to breast cancer.